Cytokinetics share price

Author: vmuj

August undefined, 2024

WebMar 2, 2024 · Cytokinetics ( NASDAQ: CYTK) announced its Q422 and FY22 results this week - in a press release, the company revealed: Net loss for the fourth quarter was … WebCytokinetics Stock Is Surging. Heart-Drug Results Are Exciting Investors. Key Stock Data P/E Ratio (TTM) N/A EPS (TTM) $-4.25 Market Cap $3.46 B Shares Outstanding 95.16 …

Cytokinetics, Incorporated Common Stock (CYTK) Stock …

WebCytokinetics stocks price quote with latest real-time prices, charts, financials, latest news, technical analysis and opinions. Your browser of choice has not been tested for use with … WebGet the latest Cytokinetics, Inc. (KK3A) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment decisions. bing tapety codzienne

Investors might be losing patience for Cytokinetics

WebDescription. Cytokinetics Inc is a biotechnology company that develops muscle biology-driven treatments for diseases characterized by reduced muscle function, muscle weakness, and fatigue. The company develops treatments for diseases such as amyotrophic lateral sclerosis, heart failure, spinal muscular atrophy, and chronic obstructive pulmonary ... WebIn terms of dividends, Cytokinetics Inc has a dividend per share of 0 and a dividend yield of 0. The company's most recent dividend date was None, and the ex-dividend date was None. CYTK's financials reveal a book value of -1.138 and earnings per share (EPS) of -4.16, with a diluted EPS (TTM) of -4.16. WebMar 29, 2024 · Price To Cash Flow (Per Share TTM) 0.00. Total Debt/Total Equity (Quarterly) 0.00. Long Term Debt/Equity (Quarterly) ... Cytokinetics Inc. is a late-stage biopharmaceutical company. The Company is ... bing taking over my google search

Cytokinetics Announces Pricing of $450 Million Convertible Senior …

Cytokinetics CYTK Stock Price, Company Overview & News - Forbes

WebApr 10, 2024 · Cytokinetics (Nasdaq:CYTK) - Stock Price, News & Analysis - Simply Wall St Stocks / United States / Pharmaceuticals & Biotech Cytokinetics NasdaqGS:CYTK … WebFeb 28, 2024 · In fact, the Most Accurate Estimate for the current quarter is currently at a loss of $1.18 per share for CYTK, compared to a broader Zacks Consensus Estimate of a loss of $1.22 per share. bing taxe quebecrepas recuperationWebAug 8, 2024 · For example, the Cytokinetics, Incorporated (NASDAQ:CYTK) share price is up a whopping 327% in the last half decade, a handsome return for long term holders. If that doesn't get you thinking about ... dababy the rock

"WebJul 1, 2024 · The initial conversion price represents a premium of 30.0% over the last reported sale price of $39.29 per share of Cytokinetics’ common stock on June 30, … " - Cytokinetics share price

Cytokinetics share price

Cytokinetics: Omecamtiv Mecarbil Rejected - Focus On …

WebSep 23, 2024 · SOUTH SAN FRANCISCO, Calif., Sept. 23, 2024 (GLOBE NEWSWIRE) -- Cytokinetics, Incorporated (Nasdaq: CYTK) today announced that the first participants have been dosed in a Phase 1 placebo ... WebView the latest Cytokinetics Inc. (CYTK) stock price, news, historical charts, analyst ratings and financial information from WSJ.

Did you know?

WebApr 6, 2024 · CYTK Cytokinetics, Incorporated Stock Price & Overview $35.39 -0.79 ( -2.18%) 1:21 PM 03/22/23 NASDAQ $USD Realtime Summary Ratings Financials … WebApr 11, 2024 · According to the issued ratings of 12 analysts in the last year, the consensus rating for Cytokinetics stock is Moderate Buy based on the current 1 hold rating and 11 buy ratings for CYTK. The average twelve-month price prediction for Cytokinetics is $56.21 with a high price target of $80.00 and a low price target of $15.00.

WebMar 16, 2024 · Cytokinetics, Incorporated Common Stock (CYTK) Stock Quotes - Nasdaq offers stock quotes & market activity data for US and global markets. WebMar 31, 2024 · On Friday 03/31/2024 the closing price of the Cytokinetics Inc share was $35.19 on NAS. Compared to the opening price on Friday 03/31/2024 on NAS of $35.02, this is a gain of 0.48%.

WebThe current Cytokinetics [ CYTK] share price is $43.11. The Score for CYTK is 56, which is 12% above its historic median score of 50, and infers lower risk than normal. CYTK is currently trading in the 50-60% percentile range relative to its historical Stock Score levels. WebMar 16, 2024 · Cytokinetics, Incorporated Common Stock (CYTK) Stock Quotes - Nasdaq offers stock quotes & market activity data for US and global markets.

WebApr 11, 2024 · The average twelve-month price prediction for Cytokinetics is $56.21 with a high price target of $80.00 and a low price target of $15.00. Do Wall Street analysts like …

WebStock analysis for Cytokinetics Inc (CYTK:NASDAQ GS) including stock price, stock chart, company news, key statistics, fundamentals and company profile. bing tapety microsoft dababy themeWebCytokinetics is a late-stage biopharmaceutical company focused on discovering, developing, and commercializing muscle activators and inhibitors. Investors & Media Cytokinetics’ unparalleled expertise has … bing tds portalWebApr 12, 2024 · Oppenheimer cut their target price on shares of Cytokinetics from $55.00 to $54.00 and set an “outperform” rating for the company in a research note on Wednesday, March 1st. bingtang fros translatedWebApr 6, 2024 · Cytokinetics initiated with buy rating, $60 price target at Truist Dec. 20, 2024 at 7:41 a.m. ET by Steve Gelsi Cytokinetics started at buy with $80 stock price target at … bing taking over chromeWeb12 hours ago · Cytokinetics Announces Inducement Grants Under Nasdaq Listing Rule 5635 (c) (4) 3 Best Stocks to Buy Now, 4/3/2024, According to Top Analysts … da baby the bopWebSectors Healthcare Biotechnology & Medical Research Cytokinetics. CYTK — Cytokinetics Share Price. $39.24 0.00 0.00%. Last trade - ... dababy then